Loading clinical trials...
Loading clinical trials...
Multimodal Identification of Depressive Symptoms
Screening with depression scales alone is subjective, and relying on single-modal data often leads to incomplete identification of symptoms that are easily missed or misdiagnosed. In this study, we first aim to use artificial intelligence to construct a depression symptom recognition model, concatenate multimodal features such as facial expression, audio, text, and postural behavior, and deeply fuse them to construct a multimodal model.
Age
60 - 100 years
Sex
ALL
Healthy Volunteers
Yes
Wuhan Mental Health Center
Wuhan, Hubei, China
Start Date
September 1, 2025
Primary Completion Date
September 1, 2026
Completion Date
December 30, 2027
Last Updated
August 11, 2025
2,000
ESTIMATED participants
data collection
OTHER
Lead Sponsor
Wuhan Mental Health Centre
NCT07360600
NCT06793397
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions